Staff Import/Export Analyst at Illumina

Singapore

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, GenomicsIndustries

Requirements

Experience in import/export operations
Knowledge of customs requirements
Experience with export and import licensing
Understanding of economic sanctions
Knowledge of classification requirements
Exceptional collaboration skills
Ability to interact effectively with external partners and government agencies

Responsibilities

Act as a subject matter expert and support day-to-day export and import operational transactions in the AMEA region
Work with Illumina’s customs brokers in the APJ region for timely and accurate customs clearances
Use SAP GTS for shipment management, SPL block release, license management, & reporting
Work with local governmental agencies to resolve import and export holds
Proactively identify, assess, and mitigate import/export risks across the AMEA region
Support the establishment and enforcement of robust internal controls
Participate in trade compliance training for internal and external partners
Collaborate with global stakeholder teams to develop and implement new trade compliance processes and initiatives across the AMEA region
Monitor and interpret new customs/trade regulations and laws in AMEA region
Maintain accurate trade data for all products, including ECCNs, HTS codes, Country of Origin, accurate valuation, and invoice accuracy, to ensure timely and compliant customs clearance
Maintain recordkeeping and document management related to import/export transactions
Support internal/external customers by providing timely updates on export/import shipments

Skills

SAP GTS

Import Operations

Export Operations

Customs Clearance

Export Licensing

Import Licensing

Economic Sanctions

ECCN Classification

HTS Codes

Trade Compliance

Risk Mitigation

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

San Diego, CaliforniaHeadquarters

1998Year Founded

$27.2MTotal Funding

IPOCompany Stage

Venture Capital, BiotechnologyIndustries

5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.

Standardizing proteomics data across platforms could challenge Illumina's data reliability.

Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.

The company offers innovative array-based solutions for DNA, RNA, and protein analysis.

Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.

Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.

Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI

Try Jobo Free